Patents Assigned to RK PHARMTECH (BEIJING) LTD.
  • Cathepsin L inhibitors
    Patent number: 11858905
    Abstract: The present disclosure provides a plurality of the compounds. The compounds are capable of inhibiting Cathepsin L (CatL). A composition including at least one of these compounds is also provided. A method for treating or preventing one or more CatL-related diseases in a subject is further provided. The method may include administering the composition to the subject.
    Type: Grant
    Filed: March 31, 2023
    Date of Patent: January 2, 2024
    Assignees: BIOFRONT THERAPEUTICS (BEIJING) CO., LTD., RK PHARMTECH (BEIJING) LTD.
    Inventors: Lichao Fang, Yayi Wang, Tianwei Ma, Ling Song, Zheng Huang, Jin-Kui Yang, Shuo Gu